NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
Back to search
Official data from USPTO
RESILIENCE MODEL OF CANCER CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RESILIENCE MODEL OF CANCER CARE
ST13
US500000098457379Class
44
Filing
98457379
Registration
8062500
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
12/09/2025
Trademark type
Word
Nice classes
44
Filing date
03/19/2024
Registration date
12/09/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
04/05/2024
First use in commerce
04/05/2024
Drawing code
4
Owner type
01
Owner location
Scottsdale, AZ, US
Examiner
DULGER, SUSAN N
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
RUBIN, Daniel
Representatives
Sandra L Etherton Etherton Law Group, LLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Multi-disciplinaryintegrativeoutpatient health care delivery and medical consultations; Health care; Health care services for treating cancer; Clinical mental health counseling services
Publications
History of USPTO decisions and trademark events.
22 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/09/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/27/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/27/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2025
GNRT
NON-FINAL ACTION E-MAILED
04/04/2025
CNRT
NON-FINAL ACTION WRITTEN
04/04/2025
IUAA
USE AMENDMENT ACCEPTED
12/10/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
10/31/2024
IUAF
USE AMENDMENT FILED
10/31/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
10/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/31/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/11/2024
GNRT
NON-FINAL ACTION E-MAILED
10/11/2024
CNRT
NON-FINAL ACTION WRITTEN
10/11/2024
DOCK
ASSIGNED TO EXAMINER
09/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2024
NWAP
NEW APPLICATION ENTERED
03/19/2024
Continuous trademark protection
Get notified about every new filing that threatens RESILIENCE MODEL OF CANCER CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.